R&D Risk Analysis
So much capital is on the line with each commitment a pharmaceutical company makes to researching a new drug. Lumivero’s suite of products can show you the likelihood of staying within budget on these initiatives and can run simulations to show you the likely outcomes of different decisions you make along the way, so you will choose with clear insight about the possible results you will experience. With Lumivero, you can back up statistical research with insights from thematic analysis of qualitative data that articulates the importance of your work. Whether you’re testing new treatments, offering a teaching hospital program, or measuring patient outcomes, Lumivero helps you centralize, code, and visualize your data for program evaluations, drug acceptability trials, and systematic reviews.